Cambridge Investment Research Advisors
XTNT icon

Cambridge Investment Research Advisors’s Xtant Medical Holdings XTNT Stock Holding History

Cambridge Investment Research Advisors’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5,357
Closed -$37K – 2237
2017
Q4 		$37K Hold
5,357
– – ﹤0.01% 2077
2017
Q3 		$46K Buy
5,357
+4,290
+402% +$38.4K ﹤0.01% 1960
2017
Q2 		$8K Sell
1,067
-500
-32% -$3.33K ﹤0.01% 1926
2017
Q1 		$12K Hold
1,567
– – ﹤0.01% 1763
2016
Q4 		$10K Buy
1,567
+217
+16% +$1.87K ﹤0.01% 1659
2016
Q3 		$18K Hold
1,350
– – ﹤0.01% 1729
2016
Q2 		$31K Sell
1,350
-267
-17% -$6.88K ﹤0.01% 1527
2016
Q1 		$53K Buy
1,617
+250
+18% +$7.99K ﹤0.01% 1555
2015
Q4 		$46K Buy
+1,367
New +$48K ﹤0.01% 1532
2014
Q3 		– Sell
-392
Closed -$32K – 1504
2014
Q2 		$32K Sell
392
-4,395
-92% -$373K ﹤0.01% 1320
2014
Q1 		$483K Buy
+4,787
New +$378K 0.02% 728

Other funds holding XTNT

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Cambridge Investment Research Advisors's XTNT Position: Q1 2018 in Review

Cambridge Investment Research Advisors sold out of Xtant Medical Holdings (XTNT) in Q1 2018, closing a stake of 5,357 shares — an estimated $37K sold.

Cambridge Investment Research Advisors first reported a position in XTNT in Q1 2014 and held it in 11 quarters. The position peaked at $483K in Q1 2014. 14 funds tracked by Wall St. Rank hold XTNT as of Q1 2018.

  • Cambridge Investment Research Advisors reported no remaining Xtant Medical Holdings position as of Q1 2018 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 5,357 Xtant Medical Holdings shares in Q1 2018, an estimated $37K.
  • Cambridge Investment Research Advisors first reported a position in Xtant Medical Holdings in Q1 2014 and held it in 11 quarters.
  • Cambridge Investment Research Advisors's Xtant Medical Holdings position peaked at $483K in Q1 2014.
  • 14 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q1 2018.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2018, filed 9 May 2018.